Form 4: Biogen Director Maria C Freire Reports Stock Acquisition and Disposal
SEC Form 4 Filing
Director Maria C Freire reports acquiring 1,340 shares of Biogen stock and disposing of 4,445 shares on June 21, 2024.
Summary
- On June 21, 2024, Maria C Freire, a director of Biogen Inc. (BIIB), engaged in transactions involving the company's common stock.
- Freire acquired 1,340 shares of common stock.
- Simultaneously, Freire disposed of 4,445 shares of common stock.
- Following these transactions, Freire beneficially owns 4,445 shares of Biogen Inc.
Sentiment
Score: 5
Explanation: This is a neutral report of stock transactions. It doesn't inherently indicate positive or negative sentiment about the company's performance.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency into the trading activities of Biogen's directors.
Stakeholder Impact
- The transactions may be of interest to shareholders as they provide insight into the actions of a company director.
Key Dates
| Date | Description |
|---|---|
| 06/21/2024 | Date of stock acquisition and disposal. |
| 06/25/2024 | Date of signature on the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.